The New York Public Health and Health Planning Council, which oversees changes in healthcare delivery, completed the approval on Sept. 12, according to a statement a Northwell spokesperson shared with Becker’s.
“This approval represents a significant milestone in creating an integrated regional health system that will elevate patient care by enhancing high-quality services for patients in New York and Connecticut,” Michael Dowling, president and CEO of Northwell Health, said in a statement shared with Becker’s. “As healthcare continues to rapidly evolve, we are committed to preserving and strengthening care for people throughout Connecticut and the Hudson Valley and look forward to building a healthier future for our communities.”
The merger now awaits Connecticut’s regulatory approval. Northwell said that until that approval is secured and the transaction closes, both organizations will continue to operate independently.
If approved, the merger would create a nonprofit regional system, combining Northwell and Nuvance’s 14,500 providers and more than 1,000 sites of care.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
